Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - B
Clinical trial NCT02811731 · COMPLETED
Trial details
- NCT number
- NCT02811731
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2015-05-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.